Alteration of brain type N-glycans in neurological mutant mouse brain
Alteration of brain type N-glycans in neurological mutant mouse brain
复制标题
DOI:
10.1093/jb/mvi125
复制
发表时间:
2005-09-01
影响因子:
2.7
通讯作者:
Hase, S
中科院分区:
文献类型:
--
作者:
Nakakita, S;Natsuka, S;Hase, S
We have previously detected two brain-specific and development-dependent N-glycans [H. Shimizu, K. Ochiai, K. Ikenaka, K. Mikoshiba, and S. Hase (1993) J. Biochem. 114, 334-338]. In the present study we attempted to analyze specific N-glycans detected in neurological mutant mice. N-glycans in cerebrum and cerebellum obtained from 3-week-old neurological mutant mice (jimpy, staggerer, and shiverer) were compared with those obtained from normal mice. N-glycans liberated from the cerebrum and cerebellum by hydrazinolysis-N-acetylation were pyridylamino, and pyridylamino derivatives of N-glycans thus obtained were separated into neutral and five acidic fractions by anion exchange chromatography. PA-N-glycans in each fraction were compared with those obtained from normal mice by reversed-phase HPLC, and the following results were obtained. The ratio of the two brain-type N-glycans, Man alpha 1-3(wGlcNAc beta 1-2Man alpha 1-6)(GlcNAc beta 1-4GlcNAc beta 1-4(Fuc alpha 1-6)GlcNac)(BA-1) to GlcNAc beta Man alpha 1-3(GlcNAc beta 1-2Man alpha 1-6)(GlcNAc beta 1-4)Man beta 1-4GlcNAc beta 1-4(Fucal-6)GlcNAc (BA-2), was higher in staggerer mice than other mutant mice and normal mice. Sia-Gal-BA-2, triantennary N-glycans, and bisected biantennary N-glycans were found in the cerebellum of shiverer and staggerer mice but not in normal or jimpy mice. High-mannose type N-glycans were not altered in mutant mice brains. The amounts of disialylbiantennary N-glycans and disialylfucosylbiantennary N-glycans were lower in jimpy mouse cerebellum than in normal mouse cerebellum, but were higher in shiverer mouse. Some alterations of N-glycans specific to mutations were successfully identified, suggesting that expression of component(s) of the N-glycan biosynthetic pathway was specifically affected in neurological mutations.